Abstract
Cells constantly adjust their metabolic state in response to extracellular signals and nutrient availability to meet their demand for energy and building blocks. Recently, there has been significant research into the metabolic aspects of embryonic stem cells/pluripotent stem cells (ESCs/PSCs) and cancer stem cells (CSCs), which has revealed the unique metabolic status of different stem cell lineages. While ESCs and CSCs were largely thought to harbor similar metabolic states, recent evidence demonstrates that their metabolic dependency is distinctly different. The glucose metabolism of ESCs largely depends on glycolysis, including a one-carbon pathway during differentiation. While proliferating cancer cells share the glycolytic phenotype of ESCs, the mitochondria-centric oxidative phosphorylation constitutes an important metabolic circuit of CSCs under metabolic stress, indicating the dynamic nature of metabolic plasticity. In this review, we catalogued metabolic signatures of cellular “stemness” to provide insights into the therapeutic potential of ESCs and CSCs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bertolini, G., L. Gatti, and L. Roz. 2014. The “stem” of chemoresistance. Cell Cycle 9(4): 628–629. doi:10.4161/cc.9.4.10821.
Chaffer, C.L., I. Brueckmann, C. Scheel, A.J. Kaestli, P.A. Wiggins, L.O. Rodrigues, M. Brooks, et al. 2011. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci U S A 108(19): 7950–7955. doi:10.1073/pnas.1102454108.
Cheong, J.H., E.S. Park, J. Liang, J.B. Dennison, D. Tsavachidou, C. Nguyen-Charles, K. Cheng, et al. 2011. Dual inhibition of tumor energy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer models. Mol Cancer Ther 10(12): 2350–2362.
Chou, T.Y., C.V. Dang, and G.W. Hart. 1995. Glycosylation of the c-Myc transactivation domain. Proc Natl Acad Sci U S A 92(10): 4417–4421.
Ciavardelli, D., C. Rossi, D. Barcaroli, S. Volpe, A. Consalvo, M. Zucchelli, A. De Cola, et al. 2014. Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment. Cell Death Dis 5: e1336. doi:10.1038/cddis.2014.285.
Dean, M., T. Fojo, and S. Bates. 2005. Tumour stem cells and drug resistance. Nat Rev Cancer 5(4): 275–284. doi:10.1038/nrc1590.
DeBerardinis, R.J. 2011. Serine metabolism: some tumors take the road less traveled. Cell Metab 14(3): 285–286. doi:10.1016/j.cmet.2011.08.004.
Dick, J.E. 2003. Breast cancer stem cells revealed. Proc Natl Acad Sci U S A 100(7): 3547–3549. doi:10.1073/pnas.0830967100.
Fan, J., J. Ye, J.J. Kamphorst, T. Shlomi, C.B. Thompson, and J.D. Rabinowitz. 2014. Quantitative flux analysis reveals folate-dependent NADPH production. Nature 510(7504): 298–302. doi:10.1038/nature13236.
Feng, W., A. Gentles, R.V. Nair, M. Huang, Y. Lin, C.Y. Lee, S. Cai, F.A. Scheeren, A.H. Kuo, and M. Diehn. 2014. Targeting unique metabolic properties of breast tumor initiating cells. Stem Cells 32(7): 1734–1745. doi:10.1002/stem.1662.
Folmes, C.D., P.P. Dzeja, T.J. Nelson, and A. Terzic. 2012. Metabolic plasticity in stem cell homeostasis and differentiation. Cell Stem Cell 11(5): 596–606. doi:10.1016/j.stem.2012.10.002.
Folmes, C.D., T.J. Nelson, A. Martinez-Fernandez, D.K. Arrell, J.Z. Lindor, P.P. Dzeja, Y. Ikeda, C. Perez-Terzic, and A. Terzic. 2011. Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. Cell Metab 14(2): 264–271. doi:10.1016/j.cmet.2011.06.011.
Gupta, P.B., C.M. Fillmore, G. Jiang, S.D. Shapira, K. Tao, C. Kuperwasser, and E.S. Lander. 2011. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 146(4): 633–644. doi:10.1016/j.cell.2011.07.026.
Hanover, J.A., M.W. Krause, and D.C. Love. 2010. The hexosamine signaling pathway: O-GlcNAc cycling in feast or famine. Biochimica et Biophysica Acta 1800(2): 80–95. doi:10.1016/j.bbagen.2009.07.017.
Hansson, J., M.R. Rafiee, S. Reiland, J.M. Polo, J. Gehring, S. Okawa, W. Huber, K. Hochedlinger, and J. Krijgsveld. 2012. Highly coordinated proteome dynamics during reprogramming of somatic cells to pluripotency. Cell Rep 2(6): 1579–1592. doi:10.1016/j.celrep.2012.10.014.
Hart, G.W., and R.J. Copeland. 2010. Glycomics hits the big time. Cell 143(5): 672–676. doi:10.1016/j.cell.2010.11.008.
Hart, G.W., C. Slawson, G. Ramirez-Correa, and O. Lagerlof. 2011. Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Annu Rev Biochem 80: 825–858. doi:10.1146/annurev-biochem-060608-102511.
Ito, K., and T. Suda. 2014. Metabolic requirements for the maintenance of self-renewing stem cells. Nat Rev Mol Cell Biol 15(4): 243–256. doi:10.1038/nrm3772.
Jang, Hyonchol., Tae.Wan. Kim, Sungho. Yoon, Soo.-Youn. Choi, Tae.-Wook. Kang, Seon.-Young. Kim, Yoo.-Wook. Kwon, Eun.-Jung. Cho, and Hong.-Duk. Youn. 2012. O-GlcNAc regulates pluripotency and reprogramming by directly acting on core components of the pluripotency network. Cell Stem Cell 11(1): 62–74. doi:10.1016/j.stem.2012.03.001.
Kreso, A., and J.E. Dick. 2014. Evolution of the cancer stem cell model. Cell Stem Cell 14(3): 275–291. doi:10.1016/j.stem.2014.02.006.
Leal, J.A., and M.E. Lleonart. 2013. MicroRNAs and cancer stem cells: therapeutic approaches and future perspectives. Cancer Lett 338(1): 174–183. doi:10.1016/j.canlet.2012.04.020.
Locasale, J.W. 2013. Serine, glycine and one-carbon units: cancer metabolism in full circle. Nat Rev Cancer 13(8): 572–583. doi:10.1038/nrc3557.
Love, D.C., M.W. Krause, and J.A. Hanover. 2010. O-GlcNAc cycling: emerging roles in development and epigenetics. Semin Cell Dev Biol 21(6): 646–654. doi:10.1016/j.semcdb.2010.05.001.
Lu, C., and C.B. Thompson. 2012. Metabolic regulation of epigenetics. Cell Metab 16(1): 9–17. doi:10.1016/j.cmet.2012.06.001.
Ma, Z., and K. Vosseller. 2013. O-GlcNAc in cancer biology. Amino Acids 45(4): 719–733. doi:10.1007/s00726-013-1543-8.
Mathieu, J., W. Zhou, Y. Xing, H. Sperber, A. Ferreccio, Z. Agoston, K.T. Kuppusamy, R.T. Moon, and H. Ruohola-Baker. 2014. Hypoxia-inducible factors have distinct and stage-specific roles during reprogramming of human cells to pluripotency. Cell Stem Cell 14(5): 592–605. doi:10.1016/j.stem.2014.02.012.
Menendez, J.A., J. Joven, S. Cufi, B. Corominas-Faja, C. Oliveras-Ferraros, E. Cuyas, B. Martin-Castillo, E. Lopez-Bonet, T. Alarcon, and A. Vazquez-Martin. 2013. The Warburg effect version 2.0: metabolic reprogramming of cancer stem cells. Cell Cycle 12(8): 1166–1179. doi:10.4161/cc.24479.
Merlo, L.M., J.W. Pepper, B.J. Reid, and C.C. Maley. 2006. Cancer as an evolutionary and ecological process. Nat Rev Cancer 6(12): 924–935. doi:10.1038/nrc2013.
Metallo, C.M., and M.G. Vander Heiden. 2010. Metabolism strikes back: metabolic flux regulates cell signaling. Genes Dev 24(24): 2717–2722. doi:10.1101/gad.2010510.
Mimeault, M., and S.K. Batra. 2014. Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies. Mol Aspects Med 39: 3–32. doi:10.1016/j.mam.2013.08.001.
Munoz, P., M.S. Iliou, and M. Esteller. 2012. Epigenetic alterations involved in cancer stem cell reprogramming. Mol Oncol 6(6): 620–636. doi:10.1016/j.molonc.2012.10.006.
Myers, S.A., B. Panning, and A.L. Burlingame. 2011. Polycomb repressive complex 2 is necessary for the normal site-specific O-GlcNAc distribution in mouse embryonic stem cells. Proc Natl Acad Sci U S A 108(23): 9490–9495. doi:10.1073/pnas.1019289108.
Nowell, P.C. 1976. The clonal evolution of tumor cell populations. Science 194(4260): 23–28.
Panopoulos, A.D., O. Yanes, S. Ruiz, Y.S. Kida, D. Diep, R. Tautenhahn, A. Herrerias, et al. 2012. The metabolome of induced pluripotent stem cells reveals metabolic changes occurring in somatic cell reprogramming. Cell Res 22(1): 168–177. doi:10.1038/cr.2011.177.
Pardal, R., M.F. Clarke, and S.J. Morrison. 2003. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 3(12): 895–902. doi:10.1038/nrc1232.
Prigione, A., B. Fauler, R. Lurz, H. Lehrach, and J. Adjaye. 2010. The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells. Stem Cells 28(4): 721–733. doi:10.1002/stem.404.
Quiros, P.M., Y. Espanol, R. Acin-Perez, F. Rodriguez, C. Barcena, K. Watanabe, E. Calvo, et al. 2014. ATP-dependent Lon protease controls tumor bioenergetics by reprogramming mitochondrial activity. Cell Rep 8(2): 542–556. doi:10.1016/j.celrep.2014.06.018.
Rafalski, V.A., E. Mancini, and A. Brunet. 2012. Energy metabolism and energy-sensing pathways in mammalian embryonic and adult stem cell fate. J Cell Sci 125(Pt 23): 5597–5608. doi:10.1242/jcs.114827.
Reya, T., S.J. Morrison, M.F. Clarke, and I.L. Weissman. 2001. Stem cells, cancer, and cancer stem cells. Nature 414(6859): 105–111. doi:10.1038/35102167.
Shafi, R., S.P. Iyer, L.G. Ellies, N. O’Donnell, K.W. Marek, D. Chui, G.W. Hart, and J.D. Marth. 2000. The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proc Natl Acad Sci U S A 97(11): 5735–5739. doi:10.1073/pnas.100471497.
Shigdar, S., Y. Li, S. Bhattacharya, M. O’Connor, C. Pu, J. Lin, T. Wang, et al. 2014. Inflammation and cancer stem cells. Cancer Lett 345(2): 271–278. doi:10.1016/j.canlet.2013.07.031.
Shiraki, N., Y. Shiraki, T. Tsuyama, F. Obata, M. Miura, G. Nagae, H. Aburatani, K. Kume, F. Endo, and S. Kume. 2014. Methionine metabolism regulates maintenance and differentiation of human pluripotent stem cells. Cell Metab 19(5): 780–794. doi:10.1016/j.cmet.2014.03.017.
Shyh-Chang, N., and G.Q. Daley. 2013. Lin28: primal regulator of growth and metabolism in stem cells. Cell Stem Cell 12(4): 395–406. doi:10.1016/j.stem.2013.03.005.
Shyh-Chang, N., G.Q. Daley, and L.C. Cantley. 2013a. Stem cell metabolism in tissue development and aging. Development 140(12): 2535–2547. doi:10.1242/dev.091777.
Shyh-Chang, N., J.W. Locasale, C.A. Lyssiotis, Y. Zheng, R.Y. Teo, S. Ratanasirintrawoot, J. Zhang, et al. 2013b. Influence of threonine metabolism on S-adenosylmethionine and histone methylation. Science 339(6116): 222–226. doi:10.1126/science.1226603.
Slawson, C., and G.W. Hart. 2011. O-GlcNAc signalling: implications for cancer cell biology. Nat Rev Cancer 11(9): 678–684. doi:10.1038/nrc3114.
Suva, M.L., N. Riggi, and B.E. Bernstein. 2013. Epigenetic reprogramming in cancer. Science 339(6127): 1567–1570. doi:10.1126/science.1230184.
Van Blerkom, J. 2009. Mitochondria in early mammalian development. Semin Cell Develop Biol 20(3): 354–364. doi:10.1016/j.semcdb.2008.12.005.
Vander Heiden, M.G., L.C. Cantley, and C.B. Thompson. 2009. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324(5930): 1029–1033. doi:10.1126/science.1160809.
Varum, S., A.S. Rodrigues, M.B. Moura, O. Momcilovic, C.A. th Easley, J. Ramalho-Santos, B. Van Houten, and G. Schatten. 2011. Energy metabolism in human pluripotent stem cells and their differentiated counterparts. PLoS One 6(6): e20914. doi:10.1371/journal.pone.0020914.
Vella, P., A. Scelfo, S. Jammula, F. Chiacchiera, K. Williams, A. Cuomo, A. Roberto, et al. 2013. Tet proteins connect the O-linked N-acetylglucosamine transferase Ogt to chromatin in embryonic stem cells. Mol Cell 49(4): 645–656. doi:10.1016/j.molcel.2012.12.019.
Vermeulen, L., M. Todaro, F. de Sousa Mello, M.R. Sprick, K. Kemper, M. Perez Alea, D.J. Richel, G. Stassi, and J.P. Medema. 2008. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci U S A 105(36): 13427–13432. doi:10.1073/pnas.0805706105.
Viale, A., P. Pettazzoni, C.A. Lyssiotis, H. Ying, N. Sanchez, M. Marchesini, A. Carugo, et al. 2014. Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. Nature 514(7524): 628–632. doi:10.1038/nature13611.
Visvader, J.E., and G.J. Lindeman. 2008. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8(10): 755–768. doi:10.1038/nrc2499.
Vlashi, E., C. Lagadec, L. Vergnes, T. Matsutani, K. Masui, M. Poulou, R. Popescu, et al. 2011. Metabolic state of glioma stem cells and nontumorigenic cells. Proc Natl Acad Sci U S A 108(38): 16062–16067. doi:10.1073/pnas.1106704108.
Wang, J., P. Alexander, L. Wu, R. Hammer, O. Cleaver, and S.L. McKnight. 2009. Dependence of mouse embryonic stem cells on threonine catabolism. Science 325(5939): 435–439. doi:10.1126/science.1173288.
Zhang, W.C., N. Shyh-Chang, H. Yang, A. Rai, S. Umashankar, S. Ma, B.S. Soh, et al. 2012. Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis. Cell 148(1–2): 259–272. doi:10.1016/j.cell.2011.11.050.
Zhu, S., W. Li, H. Zhou, W. Wei, R. Ambasudhan, T. Lin, J. Kim, K. Zhang, and S. Ding. 2010. Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell 7(6): 651–655. doi:10.1016/j.stem.2010.11.015.
Acknowledgments
This research was supported by grants from the National Cancer Center, Korea (NCC-1410672, to H. J) and was supported by a National Research Foundation of Korea (NRF) grant, funded by the Korea government (MSIP) (NRF-2011-0030705, to J-H, C).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Jang, H., Yang, J., Lee, E. et al. Metabolism in embryonic and cancer stemness. Arch. Pharm. Res. 38, 381–388 (2015). https://doi.org/10.1007/s12272-015-0558-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-015-0558-y